s6y BRAINSTORM CELL THERAPEUTICS INC. 10KSB

BRAINSTORM CELL THERAPEUTICS INC. 10KSB, filed Apr 14, 2008: ex32-2.htm

 
 
EXHIBIT 32.2
 
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

In connection with the accompanying Annual Report on Form 10-KSB of Brainstorm Cell Therapeutics Inc. for the year ended December 31, 2007, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:

(1) such Annual Report on Form 10-KSB for the year ended December 31, 2007 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in such Annual Report on Form 10-KSB for the year ended December 31, 2007 fairly presents, in all material respects, the financial condition and results of operations.
 
April 14, 2008
 /s/ David Stolick  
 
Name: David Stolick
 
Title: Chief Financial Officer (Principal Financial Officer)